Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
Q4 2025 vs. Q3 2025
How the institutions holding Abvc Biopharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 785.3K | 854.9K | +69.6K (+8.9%) |
| Value | $2.39M | $1.82M | −$566.1K (−23.7%) |
New holders (2)
Institutions that held Abvc Biopharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 10,867 | $23.1K | 0.00% |
| Morgan Stanley | 5,175 | $11.0K | 0.00% |
Sold out (2)
Institutions that held Abvc Biopharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Millennium Management LLC | 19,603 | $59.6K |
| Northwestern Mutual Wealth Management Co | 150 | $456 |